BIOXCEL THERAPEUTICS INC's ticker is and the CUSIP is 09075P955. A total of 3 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,263 | -87.9% | 17,100 | -68.2% | 0.00% | -100.0% |
| Q2 2023 | $358,308 | +326.7% | 53,800 | +1095.6% | 0.00% | – |
| Q1 2023 | $83,970 | -9.1% | 4,500 | +4.7% | 0.00% | – |
| Q4 2022 | $92,364 | -16.8% | 4,300 | -54.3% | 0.00% | – |
| Q3 2022 | $111,000 | +26.1% | 9,400 | +40.3% | 0.00% | – |
| Q2 2022 | $88,000 | -69.6% | 6,700 | -51.4% | 0.00% | – |
| Q1 2022 | $289,000 | +11.2% | 13,800 | +7.8% | 0.00% | – |
| Q4 2021 | $260,000 | -57.6% | 12,800 | -36.6% | 0.00% | -100.0% |
| Q3 2021 | $613,000 | +12.9% | 20,200 | +8.0% | 0.00% | 0.0% |
| Q2 2021 | $543,000 | -23.7% | 18,700 | +13.3% | 0.00% | 0.0% |
| Q1 2021 | $712,000 | -5.4% | 16,500 | +1.2% | 0.00% | 0.0% |
| Q4 2020 | $753,000 | -32.2% | 16,300 | -36.3% | 0.00% | -66.7% |
| Q3 2020 | $1,110,000 | -7.0% | 25,600 | +13.8% | 0.00% | -50.0% |
| Q2 2020 | $1,193,000 | -2.6% | 22,500 | -58.9% | 0.01% | -40.0% |
| Q1 2020 | $1,225,000 | – | 54,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 16,300 | $753,000 | 0.00% |
| SIMPLEX TRADING, LLC | 99 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |